Dopamine D3 receptor and improvement in positive symptoms of schizophrenia

被引：0
|
作者：
Staddon, S
Arranz, MJ
Mata, I
Munro, J
Osborne, S
Collier, D
Kerwin, R
机构：
[1] Inst Psychiat, Dept Clin Neuropharmacol, London, England
[2] Fdn Argibide, Navarra, Spain
来源：
AMERICAN JOURNAL OF MEDICAL GENETICS | 2002年 / 114卷 / 07期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
P331
引用
收藏
页码：873 / 873
页数：1
相关论文
共 50 条
  • [21] ASSOCIATION STUDIES IN SCHIZOPHRENIA USING A DOPAMINE D3 RECEPTOR GENE POLYMORPHISM
    NIMGAONKAR, VL
    ZHANG, XR
    CALDWELL, JG
    GANGULI, R
    CHAKRAVARTI, A
    SCHIZOPHRENIA RESEARCH, 1994, 11 (02) : 145 - 145
  • [22] Possible implications of the dopamine D3 receptor in schizophrenia and in antipsychotic drug actions
    Schwartz, JC
    Diaz, J
    Pilon, C
    Sokoloff, P
    BRAIN RESEARCH REVIEWS, 2000, 31 (2-3) : 277 - 287
  • [23] Dopamine D3 receptor antagonism—still a therapeutic option for the treatment of schizophrenia
    Gerhard Gross
    Karsten Wicke
    Karla U. Drescher
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2013, 386 : 155 - 166
  • [24] Association study between schizophrenia and dopamine D3 receptor gene polymorphism
    Tanaka, T
    Igarashi, S
    Onodera, O
    Tanaka, H
    Takahashi, M
    Maeda, M
    Kameda, K
    Tsuji, S
    Ihda, S
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1996, 67 (04): : 366 - 368
  • [25] Converging Evidence Implicates the Dopamine D3 Receptor Gene in Vulnerability to Schizophrenia
    Zhang, Fuquan
    Fan, Hua
    Xu, Yong
    Zhang, Kerang
    Huang, Xuezhu
    Zhu, Yan
    Sui, Manqiu
    Sun, Gaoxiang
    Feng, Kun
    Xu, Bo
    Zhang, Xiaoqian
    Su, Zhonghua
    Peng, Chunqing
    Liu, Pozi
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2011, 156B (05) : 613 - 619
  • [26] Cariprazine, a selective dopamine D3 receptor partial agonist with unique features to treat schizophrenia negative and cognitive symptoms
    Laszlovszky, I.
    Barabassy, A.
    Kiss, B.
    Szatmari, B.
    Adham, N.
    Earley, W.
    Nemeth, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S398 - S399
  • [27] Evidence for an association between the dopamine D3 receptor gene DRD3 and schizophrenia
    Ebstein, RP
    Macciardi, F
    HerescoLevi, U
    Serretti, A
    Blaine, D
    Verga, M
    Nebamov, L
    Gur, E
    Belmaker, RH
    Avnon, M
    Lerer, B
    HUMAN HEREDITY, 1997, 47 (01) : 6 - 16
  • [28] Eye fixation abnormality in schizophrenia may be related to dopamine D3 receptor gene
    Rybakowski, JJK
    Czerski, P
    Hauser, J
    Borkowska, A
    BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 41S - 42S
  • [29] Association of the MscI Polymorphism of the Dopamine D3 Receptor Gene with Tardive Dyskinesia in Schizophrenia
    Vincenzo S Basile
    Mario Masellis
    Farideh Badri
    Andrew D Paterson
    Herbert Y Meltzer
    Jeffrey A Lieberman
    Steven G Potkin
    Fabio Macciardi
    James L Kennedy
    Neuropsychopharmacology, 1999, 21 : 17 - 27
  • [30] Dopamine D3 receptor antagonism-still a therapeutic option for the treatment of schizophrenia
    Gross, Gerhard
    Wicke, Karsten
    Drescher, Karla U.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 (02) : 155 - 166
12345